Ironwood Pharmaceuticals | IRWD - Trade Debtors


Ironwood Pharmaceuticals reported $81.89M in Trade Debtors for its fiscal quarter ending in December of 2024.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 166.33M 17.95M Jun/2026
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
Almirall EUR 196.15M 20.22M Jun/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
Amarin USD 126.83M 477K Dec/2025
Ardelyx USD 82.84M 10.99M Mar/2026
Astellas Pharma JPY 844.8B 83.04B Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Charles River Laboratories USD 711.76M 11.5M Jun/2026
Coherus Biosciences USD 18.42M 232.08M Dec/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Halozyme Therapeutics USD 453.33M 4.66M Jun/2026
Incyte USD 1.13B 73.7M Jun/2026
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
Lexicon Pharmaceuticals USD 2.38M 50K Dec/2025
MacroGenics USD 10.42M 2.95M Mar/2026
Moderna USD 17M 54M Jun/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
Pacira USD 132.42M 6.78M Jun/2026
PTC Therapeutics USD 219.92M 38.3M Mar/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Sarepta Therapeutics USD 393.8M 154.11M Jun/2026
Takeda JPY 956.14B 79.79B Jun/2026
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024